Carolina Wealth Makes a Big $6 Million Bet on Novo Nordisk (NYSE: NVO)
Werte in diesem Artikel
On October 07, 2025, Carolina Wealth Advisors, LLC disclosed a buy of Novo Nordisk A/S (NYSE: NVO) shares, an estimated $6.01 million trade based on the average price for Q3 2025.According to a U.S. Securities and Exchange Commission (SEC) filing dated October 07, 2025, Carolina Wealth Advisors, LLC increased its stake in Novo Nordisk, adding 102,629 shares during the third quarter. The estimated trade size was $6.01 million, calculated using the average closing price for the period from July 1 through September 30, 2025. The updated holding stands at 116,973 shares.This transaction was a buy, raising Novo Nordisk A/S to 2.8% of the fund’s 13F reportable AUM as of Q3 2025.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Quelle: MotleyFool
Nachrichten zu Novo Nordisk
Analysen zu Novo Nordisk
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2025 | Novo Nordisk Neutral | UBS AG | |
06.10.2025 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.2025 | Novo Nordisk Neutral | UBS AG | |
01.10.2025 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
30.09.2025 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2025 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.10.2025 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
30.09.2025 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
19.09.2025 | Novo Nordisk Buy | Deutsche Bank AG | |
18.09.2025 | Novo Nordisk Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
06.10.2025 | Novo Nordisk Neutral | UBS AG | |
03.10.2025 | Novo Nordisk Neutral | UBS AG | |
23.09.2025 | Novo Nordisk Neutral | UBS AG | |
18.09.2025 | Novo Nordisk Neutral | UBS AG | |
16.09.2025 | Novo Nordisk Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
06.08.2025 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
23.06.2025 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
07.05.2025 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
17.04.2025 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.04.2025 | Novo Nordisk Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novo Nordisk nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen